SUNPHARMA - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth

1.4%

3.9%

6.9%

3.8%

3.4%

8.3%

24.5%

10y

8.4%

all

16.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,634 1.4%

1,606

1,844

Company Overview

Sales

54,964 Cr

Growth: 8.8%

Profit after Tax

10,450 Cr

Growth: 0.7%

Large Cap

3,92,147 Cr

P/E: 37.5x

Industry P/E: 30.2x

Fundamentals

Sales (Cr)	₹ 54,964
Growth	8.8%
EBITDA	28.4%
P/S	7.1x
Dividend	0.9%
P/E	37.5x
Book Value	₹ 323
PEG Ratio	4.3x
ROE	14.1%
P/B	5.1x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

7.37 %

Icici Prudential Value Discovery Fund And Various Fund Accounts

3.68 %

Sbi-Etf Nifty 50 And Various Fund Accounts

1.94 %

Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts

1.37 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts

1.24 %

Promoters

Shanghvi Finance Private Limited

40.3 %

Dilip.S.Shanghvi

9.6 %

Aditya Medisales Limited

1.67 %

Raksha S.Valia

1.2 %

Sudhir V.Valia

0.6 %

Others

Llp

2.89 %

Lakshdeep Investments & Finance (P) Ltd.

1.18 %

Iepf

0.08 %

Increase Decrease No change

Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.

Belongs to (56 Indices) view more

Investors (337)

subson

shanghvi...

varsha.k...

Followers (136)

bharath....

kiran198...

anil